Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05653648 · ClinicalTrials.gov registry record · NA
Fiber Supplementation After Bariatric Surgery
A NA study of Bariatric Surgery Candidate, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05653648: Completed NA study of Bariatric Surgery Candidate, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05653648 is a NA study of Bariatric Surgery Candidate that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 30 participants, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05653648, a NA study of Bariatric Surgery Candidate, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Test compliance and gastrointestinal tolerance of a 30-day dose of potato starch in bariatric patients, and determine if short chain fatty acids, specifically butyrate, increase in response to the dosages of potato starch.
Primary Outcome
Test gastrointestinal tolerance of a 30-day dose of potato starch in bariatric patients. Gastrointestinal tolerance will be measured using the GSRS survey (Svedlund et al, Digestive Diseases and Sciences, 1988). Statistics will use paired t-test.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Potato starch
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2024-02-28 |
| Phase | NA |
What the finished NCT05653648 record still lists
NCT05653648 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Bariatric Surgery Candidate appearing as the primary indexed condition, and to 1 intervention - of which Potato starch is the first listed.
NCT05653648 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05653648 about?
NCT05653648 is a clinical study titled "Fiber Supplementation After Bariatric Surgery". Test compliance and gastrointestinal tolerance of a 30-day dose of potato starch in bariatric patients, and determine if short chain fatty acids, specifically butyrate, increase in response to the dosages of potato starch.
What is the current status of trial NCT05653648?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-02-13. Estimated completion is 2024-02-28.
What conditions does trial NCT05653648 study?
This clinical trial studies the following conditions: Bariatric Surgery Candidate.
What interventions are being tested in trial NCT05653648?
The interventions under investigation include: Potato starch (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05653648?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05653648 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery Candidate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05653648's enrollment target sits among peer trials
30 20th of 28 higher than 6 of 28 other Bariatric Surgery Candidate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bariatric Surgery Candidate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
-
RemI for Post-Bariatric Surgery Weight Regain
RECRUITING · NA
-
Postoperative VR for Recovery After Bariatric Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI